Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer.
about
Understanding prostate-specific antigen dynamics in monitoring metastatic castration-resistant prostate cancer: implications for clinical practiceEfficacy of Cabazitaxel Treatment in Metastatic Castration Resistant Prostate Cancer in Second and Later Lines. An Experience from Two German CentersTherapies for castration-resistant prostate cancer in a new era: The indication of vintage hormonal therapy, chemotherapy and the new medicines.Reply: 'Comment on Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.Comment on 'Anti-tumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer'.
P2860
Antitumour activity of abiraterone and diethylstilboestrol when administered sequentially to men with castration-resistant prostate cancer.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Antitumour activity of abirate ...... ion-resistant prostate cancer.
@en
Antitumour activity of abirate ...... ion-resistant prostate cancer.
@nl
type
label
Antitumour activity of abirate ...... ion-resistant prostate cancer.
@en
Antitumour activity of abirate ...... ion-resistant prostate cancer.
@nl
prefLabel
Antitumour activity of abirate ...... ion-resistant prostate cancer.
@en
Antitumour activity of abirate ...... ion-resistant prostate cancer.
@nl
P2093
P2860
P50
P356
P1476
Antitumour activity of abirate ...... tion-resistant prostate cancer
@en
P2093
C J Pezaro
D Bianchini
D Dearnaley
D Mukherji
J S de Bono
R Ferraldeschi
P2860
P2888
P304
P356
10.1038/BJC.2013.446
P407
P577
2013-08-08T00:00:00Z